Literature DB >> 12867577

A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis--'DIP or not DIP revisited'.

D Kane1, L Stafford, B Bresnihan, O FitzGerald.   

Abstract

INTRODUCTION: Multiple psoriatic arthritis (PsA) classification criteria exist, but these are based on established PsA when pre-existing joint damage and the effect of medication may confound their validity. This study examined the application of the Veale classification criteria in early PsA to determine the effect of disease progression and treatment on classification and to determine the effect of the number of involved joints and the presence of distal interphalangeal (DIP) joint involvement at initial presentation on clinical and radiological outcome.
METHODS: A total of 129 patients presenting with PsA to an Irish early synovitis clinic were assessed at presentation and at 1- and 2-yr follow-up. The Veale criteria were used for PsA classification and the Sharp score of hands and feet was used to quantify radiological outcome.
RESULTS: At presentation, 52 (40%) had oligoarticular PsA and 77 (60%) had polyarticular PsA. Patients with polyarticular PsA were administered disease-modifying anti-rheumatic drugs (DMARDs) more frequently than patients with oligoarticular PsA and this resulted in a significant number of polyarticular PsA patients being reclassified as oligoarticular PsA at 1- [27/70 (39%)] and 2-yr [26/53 (49%)] follow-up. Fewer patients initially classified with oligoarticular PsA were reclassified as polyarticular PsA. More patients with oligoarticular PsA at baseline were in DMARD-free remission and there was less radiological damage at 2-yr follow-up. DIP disease was associated with other classic seronegative disease features-enthesopathy and nail dystrophy-but did not influence clinical or radiological outcome and the separation of DIP disease as a distinct subgroup in classification criteria was not supported. Synovitis-acne-pustulosis-hyperostosis (SAPHO) syndrome was not observed as a separate subgroup.
CONCLUSION: This study confirms that the application of classification criteria of PsA based on the pattern and number of involved joints may be confounded in established PsA by the effects of DMARDs. The application of classification criteria based on disease pattern prior to treatment may be more useful in studies of pathogenesis and long-term outcome in PsA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867577     DOI: 10.1093/rheumatology/keg445

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  17 in total

1.  The relationship between nail- and distal phalangeal bone involvement severity in patients with psoriasis.

Authors:  Gamze Serarslan; Hayal Güler; Sinem Karazincir
Journal:  Clin Rheumatol       Date:  2006-11-22       Impact factor: 2.980

Review 2.  Seronegative spondyloarthropathies: to lump or split?

Authors:  P Nash; P J Mease; J Braun; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

3.  Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.

Authors:  A W R van Kuijk; P Reinders-Blankert; T J M Smeets; B A C Dijkmans; P P Tak
Journal:  Ann Rheum Dis       Date:  2006-05-25       Impact factor: 19.103

4.  Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis.

Authors:  Esen Kasapoglu Gunal; Sevil Kamali; Ahmet Gul; Lale Ocal; Meral Konice; Orhan Aral; Murat Inanc
Journal:  Rheumatol Int       Date:  2008-03-04       Impact factor: 2.631

5.  Classification and categorisation of psoriatic arthritis.

Authors:  Laura C Coates; Philip S Helliwell
Journal:  Clin Rheumatol       Date:  2008-07-16       Impact factor: 2.980

6.  Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis.

Authors:  Esen Kasapoglu Gunal; Sevil Kamali; Ahmet Gul; Lale Ocal; Meral Konice; Orhan Aral; Murat Inanc
Journal:  Rheumatol Int       Date:  2008-09-03       Impact factor: 2.631

Review 7.  Psoriatic arthritis and psoriasis: differential diagnosis.

Authors:  Maddalena Napolitano; Francesco Caso; Raffaele Scarpa; Matteo Megna; Angela Patrì; Nicola Balato; Luisa Costa
Journal:  Clin Rheumatol       Date:  2016-05-07       Impact factor: 2.980

8.  Evaluation of spinal mobility measurements in predicting axial psoriatic arthritis.

Authors:  Ying-ying Leung; Kwok Wah Ho; Lai Shan Tam; Tracy Y Zhu; Lai W Kwok; Tena K Li; Emily W Kun; Edmund K Li
Journal:  Clin Rheumatol       Date:  2011-03-03       Impact factor: 2.980

9.  Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis.

Authors:  P S Helliwell; G Porter; W J Taylor
Journal:  Ann Rheum Dis       Date:  2006-07-13       Impact factor: 19.103

10.  Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis.

Authors:  B Vander Cruyssen; I E A Hoffman; H Zmierczak; M Van den Berghe; E Kruithof; L De Rycke; H Mielants; E M Veys; D Baeten; F De Keyser
Journal:  Ann Rheum Dis       Date:  2005-02-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.